← Back to Search

Time Restricted Eating for POTS

N/A
Recruiting
Led By Pam Taub, MD
Research Sponsored by University of California, San Diego
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age: 18-70 years old
Associated with related symptoms that are worse with upright posture and that improve with recumbency
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline quality of life questionnaire at 14 weeks
Awards & highlights

Study Summary

This trial is testing whether time-restricted eating can improve symptoms in people with POTS, which is a condition characterized by fatigue, lightheadedness, and tachycardia.

Who is the study for?
This trial is for adults aged 18-70 with Postural Orthostatic Tachycardia Syndrome (POTS), who experience rapid heartbeat upon standing, have a BMI under 40, and eat over a 12-hour period daily. Excluded are those with diabetes, inflammatory diseases, recent major heart events or eating disorders, pregnant or breastfeeding women, and individuals on certain diets or medications affecting appetite.Check my eligibility
What is being tested?
The study investigates if time-restricted eating can improve symptoms of POTS by targeting mitochondrial and immune dysfunction. Participants will follow an eating schedule that confines their meals to specific hours of the day to see if this impacts their energy balance and immune health.See study design
What are the potential side effects?
Time-restricted eating may lead to hunger outside of designated eating times, potential changes in mood or energy levels due to altered meal patterns, and possible digestive discomfort as the body adjusts to new eating schedules.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 70 years old.
Select...
My symptoms get worse when I stand and better when I lie down.
Select...
I have been diagnosed with POTS based on heart rate changes and symptoms.
Select...
My heart rate increases significantly when I stand up.
Select...
I am between 18 and 65 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline mitochondrial function at 14 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline mitochondrial function at 14 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Conduct a pilot clinical trial with POTS patients to assess if TRE can improve Quality of Life.
Other outcome measures
Exploratory Outcome: Assess whether POTS patients demonstrate persistent inflammatory responses and immune cell exhaustion
Exploratory Outcome: Characterize mitochondrial function in POTS patients

Trial Design

1Treatment groups
Experimental Treatment
Group I: Time restricted eatingExperimental Treatment1 Intervention
Everyone in this arm will implement a daily 8-10-hour window within which they must consume their calories. They will also be required to log their caloric intake through the use of a smartphone app.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Time restricted eating
2021
N/A
~130

Find a Location

Who is running the clinical trial?

Dysautonomia InternationalOTHER
5 Previous Clinical Trials
394 Total Patients Enrolled
5 Trials studying Postural Orthostatic Tachycardia Syndrome
394 Patients Enrolled for Postural Orthostatic Tachycardia Syndrome
University of California, San DiegoLead Sponsor
1,120 Previous Clinical Trials
1,521,382 Total Patients Enrolled
1 Trials studying Postural Orthostatic Tachycardia Syndrome
37 Patients Enrolled for Postural Orthostatic Tachycardia Syndrome
Pam Taub, MDPrincipal InvestigatorProfessor of Medicine
8 Previous Clinical Trials
1,151 Total Patients Enrolled

Media Library

Time restricted eating Clinical Trial Eligibility Overview. Trial Name: NCT05409651 — N/A
Postural Orthostatic Tachycardia Syndrome Research Study Groups: Time restricted eating
Postural Orthostatic Tachycardia Syndrome Clinical Trial 2023: Time restricted eating Highlights & Side Effects. Trial Name: NCT05409651 — N/A
Time restricted eating 2023 Treatment Timeline for Medical Study. Trial Name: NCT05409651 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who is eligible to join this scientific endeavor?

"This clinical investigation is recruiting 25 adults who have struggled with cannabis misuse, aged between 18 and 70. To qualify for the study, applicants must meet the following criteria: Age (18-65 years old), BMI (< 40 kg/m2), Upright posture heart rate increase of ≥30 bpm or >40 bpm (for those under 20 years old) from a supine position, Associated symptoms that worsen in an upright state but improve when lying down, Chronic signs lasting more than six months not caused by other conditions nor medications known to bring about orthostatic tachycardia and Daily eating period exceeding 12 hours."

Answered by AI

Are there any volunteer opportunities for this research project?

"As recorded on clinicaltrials.gov, this medical trial is open for recruitment and was initially uploaded to the website on July 1st 2022 with its last update taking place August 3rd 2022."

Answered by AI

Can minors participate in this investigation?

"This clinical trial is open to individuals aged 18 or older, with a maximum age of 70."

Answered by AI

How many participants are engaging in the research project?

"Affirmative, data from clinicaltrials.gov proves that this medical experiment is actively seeking participants. The trial was initially shared on July 1st 2022 and updated as recently as August 3rd. This investigation requires 25 individuals to be enrolled at one particular site."

Answered by AI

Who else is applying?

What state do they live in?
Texas
California
How old are they?
18 - 65
What site did they apply to?
Altman Clinical and Translational Research Institute
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
3+
~1 spots leftby Jun 2024